Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CIM
CIM logo

CIM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Chimera Investment Corp (CIM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
12.550
1 Day change
-0.79%
52 Week Range
14.880
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Chimera Investment Corp (CIM) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators are bearish, the financial performance shows declining profitability, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. Holding off for now is recommended.

Technical Analysis

The stock is showing bearish signals with the MACD below zero and negatively contracting, RSI at 35.496 indicating neutral momentum, and moving averages in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The price is near the support level of 12.629, but there is no clear indication of a reversal.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The high open interest put-call ratio suggests a slightly bearish sentiment, while the low option volume put-call ratio indicates minimal speculative activity.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
2

Positive Catalysts

  • NULL identified. There is no recent news, no positive trading trends among hedge funds or insiders, and no significant political or influential figure activity.

Neutral/Negative Catalysts

  • also experienced a significant drop of -1.79%.

Financial Performance

In Q4 2025, revenue increased by 10.48% YoY to $222.67M. However, net income dropped significantly to $6.5M (-103.86% YoY), EPS fell to 0.07 (-103.40% YoY), and gross margin declined to 28.07 (-16.41% YoY), indicating profitability challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes are available for evaluation.

Wall Street analysts forecast CIM stock price to rise
3 Analyst Rating
Wall Street analysts forecast CIM stock price to rise
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 12.650
sliders
Low
13
Averages
14.5
High
15.5
Current: 12.650
sliders
Low
13
Averages
14.5
High
15.5
RBC Capital
Outperform -> Sector Perform
downgrade
$13
AI Analysis
2025-12-09
Reason
RBC Capital
Price Target
$13
AI Analysis
2025-12-09
downgrade
Outperform -> Sector Perform
Reason
RBC Capital downgraded Chimera to Sector Perform from Outperform with a $13 price target.
RBC Capital
Kenneth Lee
Outperform
to
Sector Perform
downgrade
$6 -> $13
2025-12-09
Reason
RBC Capital
Kenneth Lee
Price Target
$6 -> $13
2025-12-09
downgrade
Outperform
to
Sector Perform
Reason
As previously reported, RBC Capital analyst Kenneth Lee downgraded Chimera to Sector Perform from Outperform with a price target of $13, up from $6, as the firm sees Chimera generating "much lower" ROE in 2026 compared to other mortgage REITs it covers and sees better relative value elsewhere in the analyst's coverage. While the firm likes the direction Chimera is taking by diversifying its revenue streams and business model, it notes that its updated model anticipates Chimera generates 2026 EAD ROE of 9.5%, which it calls "much lower" than the mid/high-teens range ROE for agency-skewed MREITs in its coverage.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CIM
Unlock Now

People Also Watch